se of blue LED in the treatment of recurrent vulvovaginal candidiasis
Not Applicable
Recruiting
- Conditions
- N77.1Candidiasis of vulva and vagina
- Registration Number
- RBR-4c88hgp
- Lead Sponsor
- Hospital de Clínicas de Porto Alegre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
Women of childbearing age and over 18 years old, with a history of recurrent vulvovaginal candidiasis and previous unsuccessful suppressive treatment. It will be necessary to confirm the diagnosis with a specific culture for Candida, associated with the presence of symptoms and changes in the physical examination suggestive of vulvovaginal candidiasis, such as whitish and lumpy vaginal secretion, pruritus of variable intensity, edema, fissures and vulvar and/or vaginal hyperemia.
Exclusion Criteria
Pregnancy, known metabolic diseases, immunosuppressive state, change of contraceptive method during the study period, use of topical or oral azoles during the study period, patients with a pacemaker or hip prosthesis, genital neoplasm.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) To evaluate the fungicidal effect of intravaginal blue light emitting diode (LED) phototherapy at 415 nm wavelength.;2) To evaluate the irradiation time of photobiomodulation therapy (FBM).;3) To evaluate the symptomatology during and at the end of the intervention.
- Secondary Outcome Measures
Name Time Method 4) To evaluate the recurrence rate of Candida species at the end of the intervention. <br>;5) To evaluate the adverse effects of intravaginal blue light emitting diode (LED) phototherapy. ;6) To evaluate the degree of general satisfaction of patients with the proposed treatment through the grade given by the patient.<br>